Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection

NCT07555431 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

146

Enrollment

OTHER

Sponsor class

Conditions

HTLV-1 Infection
HTLV I Associated Myelopathies
HTLV I Associated T Cell Leukemia Lymphoma
Neuritis

Interventions

COMBINATION_PRODUCT: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection
DRUG: Dolutegravir (DTG)

Sponsor

Carlos Brites